NICE Approves Teplizumab, First NHS Drug to Delay Type 1 Diabetes
England and Wales clear teplizumab for NHS use - the first treatment to target the cause of type 1 diabetes, delaying onset by nearly three years.
Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
England and Wales clear teplizumab for NHS use - the first treatment to target the cause of type 1 diabetes, delaying onset by nearly three years.
Continuous Coverage
A June 22 Nature paper and NASA Webb release say interstellar comet 3I/ATLAS carries isotope ratios that point…
Meteo-France has widened France's red heat alert to 54 departments for Tuesday, June 23, as schools close, nights…
A 6-3 Supreme Court restored the murder conviction of Pedro Hernandez, ending years of appeals in one of…
AbbVie's $10.9 billion deal for Apogee Therapeutics shows how aggressively big pharma is paying to protect its next…
The PWHL's first outside investors give women's hockey a louder validation test as the league pushes from fast…
After two decades in the making, NASA's most ambitious survey telescope has reached its Florida launch site, and…
Global Affairs
Keir Starmer said on June 22, 2026, that he will resign as Britain\s prime minister and Labour leader,…
Markets And Money
Lucid says it will cut about 18% of its U.S. workforce, eliminate AMP-1\s second shift and take $32…
Digital Culture
Earth crosses comet 7P/Pons-Winnecke's uneven debris this week. Most years the June Bootids barely show; in 1998 they…
Science And Wellbeing
Health officials in Maryland, Virginia, and Washington, D.C., issued overlapping measles alerts tied to Washington Dulles International Airport…
Screen And Sound
Toy Story 5 opened to $160 million in North America for a $312 million global launch, the biggest…
Fixtures And Form
Germany advanced to the World Cup knockout stage against Ivory Coast, but Nico Schlotterbeck's ankle-ligament injury has quickly…